We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
With the strike of COVID-19 global pharma events, including DIA, OCT and BIO, kept their events virtual in 2020 and 2021. However, now, with some restrictions lifted people start looking forward to having more face-to-face interaction, while getting tired of virtual events. In this episode we host Josh Karanasios, the founder of Jam55, who will share his projections on what Pharma and CRO networking will look like in 2022.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
